2PCP

ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE


Sequence Similarity Clusters for the Entities in PDB 2PCP

Entity #1 | Chains: A,C
IMMUNOGLOBULIN protein, length: 216 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 54066
95 % 75 171 206
90 % 80 181 190
70 % 815 2583 2
50 % 2125 6684 1
40 % 2126 6685 1
30 % 2141 6732 1
Entity #2 | Chains: B,D
IMMUNOGLOBULIN protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 54067
95 % 1 1 36547
90 % 1 1 34918
70 % 1017 3198 1
50 % 2126 6684 1
40 % 2127 6685 1
30 % 2142 6732 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 6UCF 1 L N123-VRC34_pI4 light chain 9606
17 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
18 5YD4 1 A, C, E, G scFv 4B08 10090
19 5YD3 1 A, C, E, G scFv 4B08 10090
20 6OC7 1 H Heavy chain of HMP42 Fab 9606
21 6OC7 2 L Light chain for HMP42 Fab 9606
22 5UD9 1 H Fab heavy chain 9606
23 5UD9 2 L Light chain 9606
24 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
25 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
26 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
27 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
28 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
29 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
30 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
31 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
32 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
33 6MEE 2 B, D antibody HEPC74 Light Chain 9606
34 6BJZ 1 H 5c8 Fab Heavy chain 9606
35 6BJZ 2 L 5c8 Fab Light chain 9606
36 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
37 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
38 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
39 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
40 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
41 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
42 4XCF 1 L 4E10 Fab light chain 9606
43 4XCF 2 H 4E10 Fab heavy chain 9606
44 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
45 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
46 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
47 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
48 6O24 1 A 4498 Fab heavy chain 9606
49 6O24 2 B 4498 Kappa light chain 9606
50 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
51 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
52 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
53 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
54 6UCE 1 L N123-VRC34_pI3 light chain 9606
55 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
56 5X08 1 H Fab 4E10 Heavy chain 9606
57 5X08 2 L Fab 4E10 Light chain 9606
58 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
59 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
60 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
61 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
62 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
63 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
64 6MEG 1 H antibody HEPC46 Heavy Chain 9606
65 6MEG 2 L antibody HEPC46 Light Chain 9606
66 5C2B 1 H scFv 3B4 9606
67 6O3K 1 L PGZL1.H4K3 light chain 9606
68 6O3K 2 H PGZL1.H4K3 heavy chain 9606
69 4XAW 1 L 4E10 Fab light chain 9606
70 4XAW 2 H 4E10 Fab heavy chain 9606
71 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
72 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
73 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
74 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
75 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
76 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
77 5UCB 1 H Fab Heavy Chain 9606
78 5UCB 2 L Fab Light Chain 9606
79 2VXV 1 H HUMAN IGG ABT-325 9606
80 2VXV 2 L HUMAN IGG ABT-325 9606
81 6QF9 1 A, B scFv 9606
82 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
83 4GXV 1 H, I Antibody 1F1, heavy chain 9606
84 4GXV 2 L, M Antibody 1F1, light chain 9606
85 2VXT 1 H MURINE IGG 125-2H 10090
86 2VXT 3 L MURINE IGG 125-2H 10090
87 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
88 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
89 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
90 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
91 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
92 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
93 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
94 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
95 5W24 1 L 5C4 Fab Light Chain 10090
96 5W24 2 H 5C4 Fab Heavy Chain 10090
97 4HPY 1 H CH59 Fab heavy chain 9606
98 4HPY 2 L CH59 Fab light chain 9606
99 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
100 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
101 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
102 4JG1 1 L Fab light chain 9606
103 4JG1 2 H Fab heavy chain 9606
104 6E65 1 L TB31F Fab light chain 9606
105 6E65 2 H TB31F Fab heavy chain 9606
106 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
107 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
108 5VF2 1 A scFv 2D10 10090
109 5I8C 1 A VRC34.01 Fab heavy chain 9606
110 5I8C 2 B VRC34.01 Fab light chain 9606
111 4O5L 1 L Fab F045-092 light chain 9606
112 4O5L 2 H Fab F045-092 heavy chain 9606
113 5MYX 1 A, C Fab c#24 light chain 10090
114 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
115 3IFL 1 L 12A11 FAB antibody light chain 10090
116 3IFL 2 H 12A11 FAB antibody heavy chain 10090
117 5WK2 1 L M116 LIGHT CHAIN 9606
118 5WK2 2 H M116 HEAVY CHAIN FD 9606
119 3PP4 1 H GA101 Fab heavy chain 10090
120 3PP4 2 L GA101 Fab light chain 10090
121 3KDM 1 A, L Immunoglobulin light chain 9606
122 3KDM 2 B, H Immunoglobulin heavy chain 9606
123 5NIV 1 A Light chain of 5D3 Fab 10090
124 5NIV 2 B Heavy chain of 5D3 Fab 10090
125 6UG7 1 L ch28/11 Fab light chain 10090
126 6UG7 2 H ch28/11 Fab heavy chain 10090
127 5N4J 1 L LIGHT CHAIN 9606
128 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
129 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
130 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
131 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
132 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
133 5X4G 1 A 6H8 Fab heavy chain 10090
134 5X4G 2 B 6H8 Fab light chain 10090
135 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
136 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
137 4PTU 1 A Antibody pn132p2C05, light chain 9606
138 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
139 4TPR 1 L If kappa light chain 10090
140 4TPR 2 H Fab heavy chain 10090
141 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
142 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
143 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
144 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
145 3IFN 1 H 12A11 FAB antibody heavy chain 10090
146 3IFN 2 L 12A11 FAB antibody light chain 10090
147 5U3P 1 H DH511.4 Fab Heavy Chain 9606
148 5U3P 2 L DH511.4 Fab Light Chain 9606
149 6BLA 1 H AMM01 Fab Heavy chain 9606
150 6BLA 2 L AMM01 Fab Light chain 9606
151 4TOY 1 H 35O22 Fab Heavy chain 9606
152 4TOY 2 L 35O22 Fab Light chain 9606
153 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
154 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
155 3NPS 2 B S4 FAB HEAVY CHAIN 9606
156 3NPS 3 C S4 FAB LIGHT CHAIN 9606
157 5I4F 1 A scFv 2D10 10090
158 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
159 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
160 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
161 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
162 5WN9 1 H scFv 2D10 9606
163 4XC3 1 L 4E10 Fab light chain 9606
164 4XC3 2 H 4E10 Fab heavy chain 9606
165 4M5Y 1 H, I Fab 5J8 heavy chain 9606
166 4M5Y 2 L, M Fab 5J8 light chain 9606
167 4TQE 1 L If kappa light chain 10090
168 4TQE 2 H Fab heavy chain 10090
169 5YY4 1 A scFv 4B08 10090
170 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
171 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
172 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
173 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
174 6Q19 1 L Fab lambda chain 9606
175 6Q19 2 H Fab heavy chain 9606
176 6PDR 1 L antibody vFP25.18 light chain 10090
177 6PDR 2 H antibody vFP25.18 heavy chain 10090
178 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
179 5VSI 2 L CH1/Ckappa Fab light chain 9606
180 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
181 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
182 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
183 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
184 5JXA 1 H VRC03 Heavy chain 9606
185 5JXA 2 L VRC03 Light chain 9606
186 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
187 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
188 6QCU 1 L Light chain 9606
189 6QCU 2 H Heavy chain 9606
190 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
191 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
192 3NTC 1 L Fab light chain 10090
193 3NTC 2 H Fab heavy chain 10090
194 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
195 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
196 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
197 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
198 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
199 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
200 6PBV 1 A, C Fab668 light chain 9606
201 6PBV 2 B, D Fab668 heavy chain 9606
202 6PZG 1 L NA-80 Fab light chain 9606
203 6PZG 2 H NA-80 Fab heavy chain 9606
204 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
205 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
206 6BE3 1 H Fab (F598) Heavy Chain 9606
207 6BE3 2 L Fab (F598) Light Chain 9606
208 4NWU 1 H APE1551 Ab Fab heavy chain 9606
209 4NWU 2 L APE1551 Ab Fab light chain 9606
210 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
211 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
212 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
213 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
214 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
215 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
216 5EWI 1 H VRC38.01 Heavy Chain 9606
217 5EWI 2 L VRC38.01 Light Chain 9606
218 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
219 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
220 5E2W 1 L AT8 LIGHT CHAIN 10090
221 5E2W 2 H AT8 HEAVY CHAIN 10090
222 5MYK 1 A Fab c#17 light chain 10090
223 5MYK 2 B Fab c#17 heavy chain 10090
224 4NZR 1 H PGT135 heavy chain Fab 9606
225 4NZR 2 L PGT135 light chain Fab 9606
226 5MYO 1 A, C Fab c#6 light chain 10090
227 5MYO 2 B, D Fab c#6 heavy chain 10090
228 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
229 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
230 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
231 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
232 5UEL 1 H 354NC102 Fab Heavy Chain 9606
233 5UEL 2 L 354NC102 Fab Light Chain 9606
234 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
235 6WIY 1 H Fab 54-1G05 heavy chain 9606
236 6WIY 2 L Fab 54-1G05 light chain 9606
237 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
238 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
239 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
240 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
241 5E2V 1 L AT8 LIGHT CHAIN 10090
242 5E2V 2 H AT8 HEAVY CHAIN 10090
243 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
244 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
245 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
246 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
247 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
248 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
249 5JUE 1 L light chain of UIC2 Fab 10090
250 5JUE 2 H heavy chain of UIC2 Fab 10090
251 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
252 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
253 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
254 5JR1 1 H 10E8 heavy chain 9606
255 5JR1 2 L 10E8 mature light chain 9606
256 6CA7 1 L PCT64_13C light chain 9606
257 6CA7 2 H PCT64_13C heavy chain 9606
258 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
259 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
260 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
261 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
262 6MVL 2 H Antibody Fab fragment heavy chain 9606
263 6MVL 3 L Antibody Fab fragment light chain 9606
264 5OB5 2 H fAb Heavy chain 9606
265 5OB5 3 L fAb Light chain 9606
266 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
267 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
268 5I66 1 A 8B6 antibody, heavy chain 10090
269 5I66 2 B 8B6 antibody, light chain 10090
270 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
271 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
272 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
273 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
274 6BZY 1 H 22D11 Heavy Chain 10090
275 6BZY 2 L 22D11 Light Chain 10090
276 3QQ9 1 C, L 101F LIGHT CHAIN 10090
277 3QQ9 2 D, H 101F HEAVY CHAIN 10090
278 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
279 5TKK 3 L mouse antibody vFP5.01 light chain 10090
280 6PLH 1 A Fab 5G12 light chain 10090
281 6PLH 2 B Fab 5G12 heavy chain 10090
282 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
283 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
284 5W6C 1 H UCA Fab heavy chain 9606
285 5W6C 2 L UCA Fab light chain 9606
286 5I1K 1 L FAB LIGHT CHAIN 9606
287 5I1K 2 H FAB HEAVY CHAIN 9606
288 3OZ9 1 L Fab NC-1 kappa light chain 10090
289 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
290 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
291 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
292 5V7U 1 L CBTAU-22.1 Fab light chain 9606
293 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
294 5UEA 1 A, H Fab Heavy Chain 9606
295 5UEA 3 B, L Fab Light Chain 9606
296 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
297 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
298 6LTG 1 A, C antibody Fab fragment H-chain 10090
299 6LTG 2 B, D antibody Fab fragment L-chain 10090
300 3G5Y 1 A 175 light chain 10090
301 3G5Y 2 B 175 heavy chain 10090
302 5NMV 1 L Fab light chain 10088
303 5NMV 2 H Fab heavy chain 10088
304 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
305 4N8C 2 L, M Light chain of monoclonal antibody 10090
306 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
307 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
308 4HGW 1 A Antibody Fab fragment, light chain 10090
309 4HGW 2 B Antibody Fab fragment, heavy chain 10090
310 1NLB 1 L antibody 19D9D6 light chain 10090
311 1NLB 2 H antibody 19D9D6 heavy chain 10090
312 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
313 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
314 3VFG 1 L 3F8 Light Chain 10090
315 3VFG 2 H 3F8 Heavy Chain 10090
316 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
317 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
318 3QRG 1 L Fab light chain 9606
319 3QRG 2 H Fab heavy chain Fd fragment 9606
320 5M6A 1 A, B, C, D Bence-Jones light chain 9606
321 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
322 4LLY 2 B, D light chain Clambda 9606
323 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
324 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
325 5EZI 1 H Fab c12 heavy chain 9606
326 5EZI 2 L Fab c12 Light chain 9606
327 4K23 1 H anti-uPAR antibody, heavy chain 10090
328 4K23 2 L anti-uPAR antibody, light chain 10090
329 3NCJ 1 L Fab15 Mut8 light chain 9606
330 3NCJ 2 H Fab15 Mut8 heavy chain 9606
331 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
332 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
333 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
334 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
335 5W05 1 L M59 FAB LIGHT CHAIN 10090
336 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
337 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
338 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
339 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
340 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
341 4M61 1 A, C Fab A52 light chain 10090
342 4M61 2 B, D Fab A52 heavy chain 10090
343 5YE3 1 B 2A7D9 VH CH1 chain 10090
344 5YE3 2 A 2A7D9 L chain 10090
345 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
346 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
347 1UM5 1 L Antibody 21H3 L chain 10090
348 1UM5 2 H Antibody 21H3 H chain 10090
349 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
350 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
351 4NWT 1 L APE1531 Ab Fab light chain 9606
352 4NWT 2 H APE1531 Ab Fab heavy chain 9606
353 3WHX 1 A mAb Fab H fragment 10090
354 3WHX 2 B mAb Fab L fragment 10090
355 3NA9 1 L Fab15 light chain 9606
356 3NA9 2 H Fab15 heavy chain 9606
357 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
358 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
359 6RCO 1 A, C R5.004 heavy chain 9606
360 6RCO 2 B, D R5.004 light chain 9606
361 6VBO 1 L DH813 light chain 9606
362 6VBO 2 H DH813 heavy chain 9606
363 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
364 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
365 4LRI 1 A, B MSL-109 Light Chain 9606
366 4LRI 2 C, P MSL-109 Heavy Chain 9606
367 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
368 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
369 4JN2 1 A, L anti dabigatran Fab 10090
370 4JN2 2 B, H anti dabigatran Fab 10090
371 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
372 4XBE 2 H 4E10 Fab heavy chain 9606
373 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
374 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
375 6BE2 1 H Fab (F598) Heavy Chain 9606
376 6BE2 2 L Fab (F598) Light Chain 9606
377 4JFZ 1 L Fab light chain 9606
378 4JFZ 2 H Fab heavy chain 9606
379 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
380 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
381 3WIF 1 A mAb Fab H fragment 10090
382 3WIF 2 B mAb Fab L fragment 10090
383 5U6A 1 A Light Chain 9606
384 5U6A 2 B Heavy Chain 9606
385 6K0Y 1 A Antibody Heavy Chain 9606
386 6K0Y 2 B Antibody Light Chain 9606
387 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
388 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
389 3MBX 1 L X836 LIGHT CHAIN 10090
390 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
391 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
392 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
393 6APC 1 H Epididymis luminal protein 214 9606
394 6APC 2 L IGL@ protein 9606
395 4HHA 1 A Fab KE5 Fab fragment KE5 9606
396 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
397 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
398 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
399 4RGO 2 H 14G8 heavy chain Fab 10090
400 4RGO 3 L 14G8 light chain Fab 10090
401 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
402 5GRY 1 A, G diabody 9606
403 5UEK 2 H Fab 12E Heavy Chain 9606
404 5UEK 3 L Fab 12E Light Chain 9606
405 3NAA 1 L Fab15 Mut5 light chain 9606
406 3NAA 2 H Fab15 Mut5 heavy chain 9606
407 1Q0X 1 L Fab 9B1, light chain 10090
408 1Q0X 2 H Fab 9B1, heavy chain 10090
409 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
410 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
411 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
412 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
413 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
414 5IK3 2 B, D 1E03 Fab fragment light chain 9606
415 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
416 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
417 5XLI 1 a, b FabL 10090
418 5XLI 2 c, d FabH 10090
419 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
420 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
421 6DC4 1 H Fab AM22 Heavy Chain 9606
422 6DC4 2 L Fab AM22 Light Chain 9606
423 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
424 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
425 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
426 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
427 4WUK 1 H CH65 heavy chain 9606
428 4WUK 2 L CH65 light chain 9606
429 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
430 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
431 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
432 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
433 5JOP 1 D, L Fab 14.22 light chain 10090
434 5JOP 2 E, H Fab14.22 heavy chain 10090
435 4HPO 1 H CH58 Fab heavy chain 9606
436 4HPO 2 L CH58 Fab light chain 9606
437 6VLN 1 H 4498 Fab heavy chain 9606
438 6VLN 2 L 4498 Fab light chain 9606
439 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
440 5UKN 2 L DH522UCA Fab fragment light chain 9544
441 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
442 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
443 5IT2 1 H heavy chain 9606
444 5IT2 2 L light chain 9606
445 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
446 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
447 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
448 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
449 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
450 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
451 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
452 5MO3 3 L Fab of monoclonal antibody, light chain 10090
453 6L8T 1 B, D, L Antibody light chain 9606
454 6L8T 2 A, C, H Antibody heavy chain 9606
455 5GZ0 1 A, C FM329 light chain 1383439
456 5GZ0 2 B, D FM329 heavy chain 1383439
457 6DW2 1 A 6078 Fab light chain 9606
458 6DW2 2 B 6078 Fab heavy chain 9606
459 6SS0 1 HHH, III Fab C0021181 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
460 6SS0 2 LLL, MMM Fab C0021181 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
461 6MG4 1 A, B JTO light chain 9606
462 6BQB 1 L MGG4 Fab light chain 9606
463 6BQB 2 H MGG4 Fab heavy chain 9606
464 4PUB 1 H DX-2930 HEAVY CHAIN 9606
465 4PUB 2 L DX-2930 LIGHT CHAIN 9606
466 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
467 6B14 2 L Light chain of Fab BL3-6S97N 10090
468 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
469 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
470 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
471 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
472 5GS3 1 A, H diabody protein 9606
473 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
474 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
475 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
476 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
477 5VKD 2 H Fab Heavy Chain 9606
478 5VKD 3 L Fab light chain 9606
479 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
480 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
481 5XHG 1 A, C polypeptide(L) 10090
482 5XHG 2 B, D polypeptide(H) 10090
483 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
484 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
485 3UYR 1 H antibody Fab heavy chain 10090
486 3UYR 2 L antibody Fab light chain 10090
487 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
488 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
489 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
490 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
491 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
492 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
493 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
494 3OAZ 2 K, L Fab 2G12, light chain 9606
495 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
496 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
497 1ZAN 1 L Fab AD11 Light Chain 10116
498 1ZAN 2 H Fab AD11 Heavy Chain 10116
499 6CJK 1 A, C Immunoglobulin Fab light chain 9986
500 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
501 4N0Y 1 H IGH526 Heavy Chain 9606
502 4N0Y 2 L IGH526 Light Chain 9606
503 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
504 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
505 6OTC 2 H sFab H3 heavy chain 32630
506 6OTC 3 L sFab H3 light chain 32630
507 6Q1G 1 L H1244 Fab lambda chain 9606
508 6Q1G 2 H H1244 Fab heavy chain 9606
509 5MTH 1 A, H antibody Fab heavy chain 10090
510 5MTH 2 B, L antibody Fab light chain 10090
511 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
512 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
513 6O26 1 A 3246 Fab heavy chain 9606
514 6O26 2 B 3246 Fab light chain 9606
515 1RZF 1 L Fab E51 light chain 9606
516 1RZF 2 H Fab E51 heavy chain 9606
517 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
518 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
519 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
520 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
521 6WJ0 1 H Fab 54-4H03 heavy chain 9606
522 6WJ0 2 L Fab 54-4H03 light chain 9606
523 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
524 4KTE 2 L GE148 Light Chain Fab 9544
525 5I8O 1 H HMM5 antibody heavy chain 9606
526 5I8O 2 L HMM5 antibody light chain 9606
527 4JG0 1 L Fab light chain 9606
528 4JG0 2 H Fab heavy chain 9606
529 6LKT 1 A antibody Fab fragment H chain 10090
530 6LKT 2 B antibody Fab Fragment L-chain 10090
531 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
532 4YGV 2 B, L aDabi-Fab2a light chain 9606
533 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
534 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
535 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
536 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
537 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
538 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
539 3EO0 1 A, C GC-1008 Fab Light Chain 10090
540 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
541 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
542 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
543 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
544 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
545 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
546 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
547 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
548 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
549 4FQI 3 H antibody CR9114 heavy chain Fab 9606
550 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
551 6S5A 2 H anti P329G LALA Fab heavy chain 10090
552 6S5A 3 L anti P329G LALA Fab light chain 10090
553 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
554 4JHA 2 L D25 light chain 9606
555 6SS5 1 HHH Fab C0020187 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
556 6SS5 2 LLL Fab C0020187 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
557 6B9Z 1 A Trastuzumab Fab light chain 10090
558 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
559 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
560 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
561 4PTT 1 A Antibody pn132p2C05, light chain 9606
562 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
563 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
564 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
565 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
566 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
567 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
568 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
569 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
570 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
571 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
572 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
573 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
574 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
575 4DGV 1 H HCV1 Heavy Chain Fab 9606
576 4DGV 2 L HCV1 Light Chain 9606
577 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
578 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
579 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
580 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
581 5TH2 1 A, C cetuximab Fab, light chain 10090
582 5TH2 2 B, D cetuximab Fab, heavy chain 10090
583 5I8K 1 L HHH1 Fab Light chain 9606
584 5I8K 2 H HHH1 Fab Heavy chain 9606
585 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
586 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
587 6ULF 1 A 4498 Fab heavy chain 9606
588 6ULF 2 B 4498 Fab light chain 9606
589 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
590 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
591 1YNL 1 L Ig gamma light chain 10090
592 1YNL 2 H Ig gamma heavy chain 10090
593 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
594 5EPM 2 B, F Antibody Fab fragment light chain 10090
595 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
596 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
597 3UMT 1 A scFv heavy chain and light chain 10090
598 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
599 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
600 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
601 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
602 6UC5 1 H Fab397 heavy chain 9606
603 6UC5 2 L Fab397 light chain 9606
604 6PEC 1 L antibody light chain 9544
605 6PEC 2 H antibody heavy chain 9544
606 4NUJ 1 A PGT152 light chain 9606
607 4NUJ 2 B PGT152 heavy chain 9606
608 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
609 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
610 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
611 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
612 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
613 3U2S 2 B, L PG9 light chain 9606
614 6PE7 1 H FAB Heavy Chain 9606
615 6PE7 2 L FAB Light chain 9606
616 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
617 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
618 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
619 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
620 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
621 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
622 4NUG 1 L PGT151 light chain 9606
623 4NUG 2 H PGT151 heavy chain 9606
624 7BZ5 2 H Heavy chain of B38 9606
625 7BZ5 3 L Light chain of B38 9606
626 3IU4 1 H chP3 Fab heavy chain 10090
627 3IU4 2 L chP3 Fab light chain 10090
628 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
629 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
630 6DC8 1 L IgG light chain 10090
631 6DC8 2 H IgG heavy chain 10090
632 6NYQ 1 L 1H3 Fab light chain 10090
633 6NYQ 2 H 1H3 Fab heavy chain 10090
634 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
635 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
636 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
637 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
638 6IAS 1 H Fab NKp46-1 heavy chain 32630
639 6IAS 2 L Fab NKp46-1 light chain 32630
640 1P7K 1 A, L antibody light chain FAB 10090
641 1P7K 2 B, H antibody heavy chain FAB 10090
642 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
643 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
644 3RVV 2 C 4C1 - light chain 10090
645 3RVV 3 D 4C1 - heavy chain 10090
646 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
647 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
648 3P0Y 2 H Fab DL11 heavy chain 9606
649 3P0Y 3 L Fab DL11 light chain 9606
650 4NPY 1 A, L germline PGT121 light chain Fab 9606
651 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
652 6ANA 2 H LL2 Fab Heavy Chain 10090
653 6ANA 3 L LL2 Fab Light Chain 10090
654 5IBU 1 B, L 6652 Light Chain 9606
655 5IBU 2 G, H 6652 Heavy Chain 9606
656 5VPL 2 C 4C1 - LIGHT CHAIN 10090
657 5VPL 3 D 4C1 - HEAVY CHAIN 10090
658 6AOD 1 A FXIa Antibody FAB Light Chain 9606
659 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
660 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
661 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
662 2YPV 2 H FAB 12C1 10090
663 2YPV 3 L FAB 12C1 10090
664 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
665 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
666 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
667 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
668 4JY5 1 L PGT122 light chain Fab 9606
669 4JY5 2 H PGT122 heavy chain Fab 9606
670 6ELE 1 A, H fAB heavy chain 9606
671 6ELE 2 B, L fAB light chain 9606
672 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
673 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
674 6B5R 1 H CIS42 Fab Heavy chain 9606
675 6B5R 2 L CIS42 Fab Light chain 9606
676 3NAC 1 L Fab15 Mut7 light chain 9606
677 3NAC 2 H Fab15 Mut7 heavy chain 9606
678 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
679 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
680 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
681 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
682 1Q72 1 L Fab M82G2, Light chain 10090
683 1Q72 2 H Fab M82G2, Heavy chain 10090
684 6XCA 1 H C105 Heavy Chain 9606
685 6XCA 2 L C105 Light Chain 9606
686 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
687 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
688 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
689 6MNQ 3 L Ab DH727.2 light chain 9544
690 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
691 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
692 4YHO 1 H aDabi-Fab3 heavy chain 9606
693 4YHO 2 L aDabi-Fab3 light chain 9606
694 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
695 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
696 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
697 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
698 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
699 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
700 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
701 4DGY 1 H HCV1 Heavy Chain Fab 9606
702 4DGY 2 L HCV1 Light Chain 9606
703 5EN2 1 A GD01 heavy chain 10090
704 5EN2 2 B GD01 light chain 10090
705 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
706 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
707 6P4Y 1 H 4A10 Fab heavy chain 10090
708 6P4Y 2 L 4A10 Fab light chain 10090
709 3MXW 2 L 5E1 light chain 9606
710 3MXW 3 H 5E1 heavy chain 9606
711 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
712 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
713 3EO9 1 L Efalizumab Fab fragment, light chain 9606
714 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
715 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
716 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
717 6N35 1 K, L Fab 2G12 light chain 9606
718 6N35 2 H, M Fab 2G12 heavy chain 9606
719 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
720 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
721 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
722 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
723 5WUV 1 L light chain 9606
724 5WUV 2 H heavy chain 9606
725 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
726 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
727 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
728 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
729 4JM4 1 H PGT 135 Heavy Chain Fab 9606
730 4JM4 2 L PGT 135 Light Chain Fab 9606
731 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
732 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
733 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
734 5YE4 2 B, D 1A9D7 L chain 10090
735 6B0G 1 C 1245 Antibody, Light Chain 9606
736 6B0G 2 D 1245 Antibody, Heavy Chain 9606
737 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
738 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
739 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
740 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
741 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
742 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
743 6D0X 1 A 2140 Antibody, heavy chain 9606
744 6D0X 2 B 1210 Antibody, light chain 9606
745 6UUD 1 H 5D5 Antibody Fab, heavy chain 10090
746 6UUD 2 L 5D5 Antibody Fab, light chain 10090
747 6BE4 1 H Fab (F598) Heavy Chain 9606
748 6BE4 2 L Fab(F598) Light Chain 9606
749 5TPP 1 L DH270.5 Fab heavy chain 9606
750 5TPP 2 H DH270.5 Fab light chain 9606
751 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
752 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
753 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
754 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
755 6P7H 1 B Antibody DF2F-b.04 light chain 9479
756 6P7H 2 A Antibody DF2F-b.04 heavy chain 9479
757 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
758 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
759 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
760 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
761 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
762 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
763 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
764 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
765 5TL5 1 L M2177 LIGHT CHAIN 10090
766 5TL5 2 H M2177 HEAVY CHAIN 10090
767 2FX7 1 L Fab 4E10 Light Chain 9606
768 2FX7 2 H Fab 4E10 Heavy Chain 9606
769 6O39 1 A Antibody F2.I Fab, Light chain 9606
770 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
771 5Y9K 1 L belimumab light chain 9606
772 5Y9K 2 H belimumab heavy chain 9606
773 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
774 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
775 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
776 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
777 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
778 6GLW 3 D, L Fab 1D11 - Light chain 9844
779 3WFH 1 A mAb Fab H fragment 10090
780 3WFH 2 B mAb Fab L fragment 10090
781 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
782 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
783 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
784 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
785 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
786 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
787 6GKU 2 H Fab 6F5 - Heavy Chain 9844
788 6GKU 3 L Fab 6F5 - Light chain 9844
789 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
790 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
791 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
792 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
793 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
794 5HI4 3 D, L CAT-2000 FAB light chain 9606
795 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
796 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
797 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
798 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
799 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
800 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
801 3RVW 2 C 4C1 - light chain 10090
802 3RVW 3 D 4C1 - heavy chain 10090
803 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
804 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
805 5XKU 2 B HNIgGA6 light chain 9606
806 5XKU 3 C HNIgGA6 heavy chain 9606
807 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
808 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
809 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
810 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
811 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
812 5HI5 3 D, L CAT-2000 light chain 9606
813 5JO5 1 A, C, E, H 10E8 gHV 9606
814 5JO5 2 B, D, F, L 10E8 gLV 9606
815 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
816 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
817 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
818 5CCK 2 L Antibody 3BC315 Fab light chain 9606
819 6GXX 1 H FAB 1D9 heavy chain 10090
820 6GXX 2 L FAB 1D9 light chain 10090
821 6JP7 1 H immunoglobulin Fab heavy chain 9606
822 6JP7 2 L immunoglobulin Fab light chain 9606
823 5I76 1 A, C FM318_light_chain 1383439
824 5I76 2 B, D FM318_heavy_cahin 1383439
825 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
826 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
827 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
828 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
829 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
830 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
831 5I18 1 L FAB LIGHT CHAIN 9606
832 5I18 2 H FAB HEAVY CHAIN 9606
833 6QB3 2 X scFv55 9606
834 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
835 4JN1 2 L anti-dabigatran Fab1, light chain 10090
836 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
837 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
838 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
839 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
840 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
841 4G5Z 2 L canakinumab antibody fragment light chain 9606
842 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
843 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
844 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
845 6SF6 1 A, H COMP-reactive monoclonal antibody 15A Fab fragment, heavy chain 10090
846 6SF6 2 B, L COMP-reactive monoclonal antibody 15A Fab fragment, light chain 10090
847 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
848 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
849 2OK0 2 L Fab ED10 light chain 10090
850 2OK0 3 H Fab ED10 heavy chain 10090
851 6P4C 1 L HyHEL10 Fab light chain 10090
852 6P4C 2 H HyHEL10 Fab heavy chain 10090
853 3SOB 1 L antibody light chain 9606
854 3SOB 3 H antibody heavy chain 9606
855 6UG8 1 L ch28/11 Fab light chain 10090
856 6UG8 2 H ch28/11 Fab heavy chain 10090
857 6B5M 1 H CIS43 Fab Heavy chain 9606
858 6B5M 2 L CIS43 Fab Light chain 9606
859 5AWN 1 H Heavy chain of 3BC176 Fab 9606
860 5AWN 2 L Light chain of 3BC176 Fab 9606
861 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
862 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
863 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
864 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
865 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
866 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
867 5DR5 2 L AbD09097 Fab light chain 9606
868 6MG5 1 A, B Light chain JTO 9606
869 2IH3 1 A FAB Heavy Chain 10090
870 2IH3 2 B FAB Light Chain 10090
871 4KQ3 1 L CNTO3186 light chain Fab 9606
872 4KQ3 2 H CNTO3186 heavy chain Fab 9606
873 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
874 6AQ7 3 L POM6 FAB light CHAIN 10090
875 4JFX 1 A, L Fab light chain 9606
876 4JFX 2 B, H Fab heavy chain 9606
877 3SGE 1 I, L Light Chain 10090
878 3SGE 2 H, J Heavy Chain 10090
879 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
880 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
881 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
882 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
883 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
884 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
885 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
886 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
887 5FHB 1 H Antibody 100 Fab heavy chain 9606
888 5FHB 2 L Antibody 100 Fab light chain 9606
889 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
890 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
891 1JGU 1 L Antibody Light Chain 10090
892 1JGU 2 H Antibody Heavy Chain 10090
893 4I77 1 H Lebrikizumab heavy chain Fab 9606
894 4I77 2 L Lebrikizumab light chain Fab 9606
895 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
896 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
897 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
898 4O4Y 2 H 2095-2 heavy chain 9986
899 5OBF 1 H fAb Heavy chain 10090
900 5OBF 2 L fAb Light chain 10090
901 6QNK 1 A, C FAB light chain 10090
902 6QNK 2 B, D FAB heavy chain 10090
903 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
904 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
905 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
906 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
907 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
908 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
909 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
910 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
911 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
912 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
913 5MHE 1 L Fab-fragment 10090
914 5MHE 2 H Fab-fragment 10090
915 5YFI 1 L Light chain of Fab fragment 10090
916 5YFI 2 H Heavy chain of Fab fragment 10090
917 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
918 4GLR 3 I, K anti-ptau light chain light chain 9031
919 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
920 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
921 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
922 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
923 4HJG 1 A Trastuzumab light chain 9606
924 4HJG 2 B Trastuzumab heavy chain 9606
925 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
926 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
927 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
928 5I30 1 L Fab PL-2 light chain 10090
929 5I30 2 H Fab PL-2 heavy chain 10090
930 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
931 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
932 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
933 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
934 6CT7 1 B, L BIIB054 Fab light chain 9606
935 6CT7 2 A, H BIIB054 Fab heavy chain 9606
936 3FN0 1 L Fab Z13e1 light chain 9606
937 3FN0 2 H Fab Z13e1 heavy chain 9606
938 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
939 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
940 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
941 4YHI 2 B, L aDabi-Fab2a light chain 9606
942 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
943 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
944 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
945 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
946 4OSU 1 H SM5-1 Fab Heavy Chain 9606
947 4OSU 2 L SM5-1 Fab Light Chain 9606
948 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
949 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain